Latest News
|
THE UNITED REPUBLIC OF TANZANIA MINISTRY OF HEALTH TANZANIA MEDICINES AND MEDICAL DEVICES AUTHORITY |
|
ISO 9001: 2015 CERTIFIED
PUBLIC NOTICE
17th August, 2026
NOTICE ON SUBMISSION OF BIENNIAL POST - MARKETING SURVEILLANCE (PMS) REPORTS FOR MEDICAL DEVICES AND IN VITRO DIAGNOSTICS
- The Tanzania Medicines and Medical Devices Authority (TMDA) wishes to remind all registrants, Marketing Authorization Holders (MAHs), manufacturers, and other relevant stakeholders on their obligation to comply with the Post-Marketing Surveillance (PMS) reporting requirements applicable to registered medical devices and in vitro diagnostics (IVDs).
- Pursuant to regulation 17(3) of the Medical Devices Regulations, 2015 (GN. No. 315), every registrant is required to submit biennial PMS reports to TMDA, including information on adverse events and incidents associated with registered medical devices or IVDs.
- Accordingly, all registrants of medical devices and IVDs are required to ensure that the prescribed biennial PMS reports are dully prepared and submitted to TMDA within applicable reporting timelines in accordance with the requirements of the Regulations.
- PMS reports shall provide adequate information on the quality, safety, and performance of the registered device or IVD, including, where applicable, adverse events and incidents, complaints, safety signals identified through post-marketing monitoring, Field Safety Corrective Actions (FSCAs), Field Safety Notices (FSNs), recalls, corrective actions, vigilance information and other relevant information.
- Registrants and manufacturers are urged to review their PMS obligations and ensure timely submission of all outstanding and subsequent reports. It should be noted that PMS reporting does not replace the obligation to promptly report adverse events, incidents, safety signals, FSCAs, recalls, or other reportable events as separately required.
- Registrants, MAHs and manufacturers must ensure that the information submitted is complete, accurate, current, and sufficient to enable TMDA to effectively assess and take appropriate regulatory actions where necessary.
- Failure to submit required PMS reports or other mandatory post-marketing safety information, may constitute non-compliance and may result in appropriate regulatory action to be taken by the Authority.
- For further information or clarification, stakeholders are advised to contact or visit TMDA Headquarters in Dodoma or the nearest TMDA Zone Office as highlighted hereunder.
|
Name |
Address |
Regions served |
|
Eastern Lake Zone |
Nyasaka Road, Nyakato Buzuruga, P.O. Box 543, Ilemela, Mwanza, Tanzania |
1.Mwanza 2.Mara 3.Simiyu |
|
Southern Highlands Zone |
NHIF Tower, 3rd Floor, E-mail: info.mbeya@tmda.go.tz |
1.Mbeya 2.Njombe 3.Rukwa 4.Songwe |
|
Northern Zone |
Makongoro and Goliondoi Road, P.O. Box 16609, Arusha, Tanzania |
1.Arusha 2.Kilimanjaro 3.Manyara |
|
Eastern Zone |
Mandela Road, Mabibo – External, P.O. Box 31356, Dar es salaam, Tanzania |
1.Dar es Salaam 2.Coast 3.Tanga |
|
Central Zone |
Old Dar es Salaam Road, |
1.Morogoro 2.Dodoma 3.Iringa 4.Singida |
|
Southern Zone |
NBC Building, 1st floor, Serengeti Road, E-mail: info.ruvuma@tmda.go.tz |
1.Ruvuma 2.Lindi 3.Mtwara |
|
Western Zone |
NSSF Akiba Commercial Complex, Jamhuri Street, 1st floor, Wing A, P.O Box 520, Tabora, Tanzania E-mail: tabora@tmda.go.tz |
1.Tabora 2.Kigoma 3.Katavi |
|
Western Lake Zone |
Nyerere Road, Central Gold Market, Geita Town Council P.O. Box 240, Geita, Tanzania Mob: +255 654 817 849 |
1.Geita 2.Kagera 3.Shinyanga |
Director General
Tanzania Medicines and Medical Devices Authority,
Plot No. 56/1,
Block E, Kisasa B Centre, Hombolo Road,
P.O. Box 1253, Dodoma or
P.O. Box 77150, Dar es Salaam
Phone: +255 22 2452108 / 2450512 / 2450751
Fax No.: +255 22 2450793
Toll-Free Number: 0800110084